Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01878695 · ClinicalTrials.gov registry record · Phase 1
Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer
A Phase 1 study of Stage 0/1 Breast Cancer and Post Biopsy, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT01878695 is a Phase 1 study of Stage 0/1 Breast Cancer and Post Biopsy that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. The registered enrollment target is 13 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01878695, a Phase 1 study of Stage 0/1 Breast Cancer and Post Biopsy, has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
NAC is the N-acetyl derivative of the naturally occurring amino acid, L-cysteine. It is a common over-the-counter supplement and also is available as an injectable pharmaceutical that protects the liver in cases of acetaminophen overdose. In the exercise physiology literature, both oral and injectable NAC have been shown to reduce fatigue and improve recovery from exertion which has interesting implications for exploring cancer-related fatigue. In terms of cancer cell biology, reactive oxygen species (ROS) may play an important role in the development and progression of breast cancer
Conditions Studied
Interventions
- DRUG IV/oral n-acetylcysteine
Study Locations (1)
Pennsylvania
- Jefferson Myrna Brind Center for Integrative Medicine - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2012-07-26 |
| Est. Completion | 2015-05-14 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01878695
The ClinicalTrials.gov registry entry for NCT01878695 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Stage 0/1 Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which IV/oral n-acetylcysteine is the first listed.
NCT01878695 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01878695 about?
NCT01878695 is a clinical study titled "Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer". NAC is the N-acetyl derivative of the naturally occurring amino acid, L-cysteine. It is a common over-the-counter supplement and also is available as an injectable pharmaceutical that protects the liver in cases of acetaminophen overdose. In the exercise physiology literature, both oral and injectab...
What is the current status of trial NCT01878695?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2012-07-26. Estimated completion is 2015-05-14.
What conditions does trial NCT01878695 study?
This clinical trial studies the following conditions: Stage 0/1 Breast Cancer, Post Biopsy, Pre-surgery.
What interventions are being tested in trial NCT01878695?
The interventions under investigation include: IV/oral n-acetylcysteine (DRUG).
Who is sponsoring clinical trial NCT01878695?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01878695 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.